1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow PTG-100 peptide: new trials by email Literature Review of PTG-100 peptide trials Research Report on PTG-100 peptide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PTG-100 for Patients With Celiac Disease PTG-100, Placebo - Celiac Disease | Phase 1 | Completed | Nielsen Fernandez-Becker | 12 | 2021-02-26 | 2022-05-23 |
| Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis PTG-100, Placebo - Ulcerative Colitis | Phase 2 | Terminated | Protagonist Therapeutics, Inc. | 98 | 2016-12-01 | 2025-08-21 |
Celiac Disease (1) · Colitis, Ulcerative (1) · Inflammatory Bowel Diseases (1)
Nielsen Fernandez-Becker (1) · Protagonist Therapeutics, Inc. (1)
United States (2) · Australia (1) · Belgium (1) · Bosnia and Herzegovina (1) · Canada (1) · Croatia (1) · Czechia (1) · Germany (1) · Hungary (1) · Latvia (1) · Netherlands (1) · New Zealand (1) · Poland (1) · Russia (1) · Serbia (1)
Nielsen Q Fernandez-Becker, MD, PhD (1)